![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2014/11/colon11251-300x225.jpg)
Hyaluronan driven by epithelial aPKC deficiency remodels the microenvironment and creates a vulnerability in mesenchymal colorectal cancer
Highlights Reduced aPKC drives HA deposition, the mCRC phenotype, and predicts poor survival• HA enhances malignancy and promotes CAF and epithelial heterogeneity in mCRC• Immunosuppression